A new review looked at three newer ways to treat Type II endoleaks, a complication that can happen after endovascular aneurysm repair (EVAR). The techniques are transcaval embolization (TCE), laser-assisted transgraft embolization (LATE), and shape memory polymer (SMP) embolization. The review included observational studies, but the number of patients and follow-up time were not reported.
The review found that TCE and LATE had encouraging early technical and clinical outcomes. For SMP embolization, the review reported significant sac shrinkage in more than 85% of patients and that it prevented clinically significant Type II endoleaks. However, the review did not provide details on safety, such as adverse events or side effects.
The main limitation is that the evidence remains limited. Larger studies are needed to confirm long-term outcomes and to define the best use of these techniques. The review suggests these methods are promising alternatives to conventional embolization, with high technical success and the potential to reduce reinterventions.
For patients, this means there are new options being explored for Type II endoleaks, but more research is needed before they become standard. Anyone with a Type II endoleak should discuss treatment options with their doctor.